TBPH vs MSFT: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Microsoft Corporation in 2026
TBPH
Theravance Biopharma Inc
—
MSFT
Microsoft Corporation
$401.10
Key Metrics Comparison
| Metric | TBPH | MSFT | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $3.71T | MSFT |
| P/E Ratio | 7.49 | 38.61 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or MSFT a better investment?
Comparing TBPH and MSFT: Theravance Biopharma Inc has a market cap of $861.45M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and MSFT?
TBPH (Theravance Biopharma Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or MSFT?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 38.6x).
Which is growing faster: TBPH or MSFT?
Both TBPH and MSFT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or MSFT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $861.45M for TBPH.
Should I buy TBPH or MSFT in 2026?
Both TBPH and MSFT have investment merit. TBPH trades at $N/A while MSFT trades at $401.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and MSFT stock?
Key differences: Market Cap ($861.45M vs $3.71T), P/E Ratio (7.5x vs 38.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or MSFT in 2026?
The choice between TBPH and MSFT depends on your investment goals. MSFT shows higher revenue growth (0.0%). MSFT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and MSFT?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.